{"path":"Images/Pasted image 20240220134425.png","text":"Anticoagulant Class ~ Examples. Route HalFlife Mechanism of acon Effect on cloting ‘Specific assays ‘Reversal agents to consider Tests. in major bleeding Vitamin K antagonist Warfarin PO 40-70h Vitamin K eporide PTITT R Vitamin K VKA Sinthrome reductase inhibition — APTT 11 Prothrombin Complex Concentrate (PCC) Coumadin factors I, VI, X, X, Fib protein C, 5,2 et Unfractionated heparin Unfractionated IV 30 mins—4 h Potentiation of T o/t APTT ratio Proamine heparin antithrombin — targets APTT 111 a, Xa, Xa, Xia Fib < et Low molecular weight Enoxaparin S 3-6h Potentiation of PT o/t “Anti Xa Level using Consider Protamine if <16 hr of Heparin Dalteparin Fs antithrombin — targets APTT 11 respective LMWH admiistration Tinzaparin < Xa, lla, tissue factor Fib pathway inhibitor e/t indrect Xa inhibitor Fondaparinux SC 17-20h Taget Xa inhibition, PTe/11 “Anti Xa Level using No antidote through potentation of ~ APTT </t fondaparinux Consider Tranexamic acid + PCC in severe antithrombin Fib bleeding e Direct Xa inhibitors Apixaban POBD 8-15h DirectXainhibition T «+/11 “Anti Xa Level using No reversal agent yet avalable (Andexanat Riaroxaban POOD 5-13h APTT /1 respective drugs Alpha awaiting licence) Edoxaban POOD 10-14h Fib - e Tranesaic acid Consider PCC in severe bleeding Direct thrombin inhibitors Dabigatran PO 12-17h Direct thrombin PT 1/APTT 11 “Haemodlot Assay or Idaricizumab if available Agartoban 8D 4smin inhibition fib 1 dilute thrombin time o antidote for parenteral Direct Thrombin Bivalrirudin NV 25min LARIER] inhibitors. Hinscin v 12k v","libVersion":"0.3.2","langs":"eng"}